Table 1. Baseline information of participants.
| Placebo (N=40) | B-3 (N=40) | ||
|---|---|---|---|
| Sex (male, female) | 37, 3 | 37, 3 | |
| Age | 45.6 ± 8.5 | 45.4 ± 9.8 | |
| Anthropometric measures | |||
| Height (cm) | 170.4 ± 7.0 | 170.5 ± 5.9 | |
| Body weight (kg) | 80.3 ± 7.1 | 80.6 ± 6.8 | |
| BMI (kg/m2) | 27.6 ± 1.2 | 27.7 ± 1.2 | |
| Waist circumference (cm) | 96.2 ± 5.6 | 96.6 ± 4.9 | |
| Abdominal fat areas | |||
| Visceral fat area (cm2) | 106.1 ± 20.7 | 106.3 ± 20.3 | |
| Subcutaneous fat area (cm2) | 233.4 ± 40.9 | 233.2 ± 36.2 | |
| Whole body fat area (cm2) | 339.6 ± 54.2 | 339.6 ± 47.1 | |
| Body composition | |||
| Body fat mass (kg) | 23.6 ± 4.2 | 22.9 ± 3.1 | |
| Body fat (%) | 29.5 ± 5.4 | 28.5 ± 3.9 | |
| Muscle mass (kg) | 53.6 ± 6.8 | 54.5 ± 6.2 | |
Continuous variables are shown as means ± SD.